FAST (Fluid Accumulation Status Trial)

NACompletedINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

April 30, 2008

Conditions
Congestive Heart FailureCardiomyopathyDyspneaPulmonary EdemaHeart Diseases
Interventions
DEVICE

Fluid Status Monitoring (OptiVol™)

Thoracic Fluid Status Software downloaded on all subjects enrolled in the trial

Trial Locations (16)

11030

North Shore University Hospital, Manhasset

18901

The Pavillion at Doylestown Hospital, Doylestown

27710

Duke University Medical Center, Durham

33462

Palm Beach Heart Institute, Atlantis

43210

The Ohio State University Hospital, Columbus

44195

Cleveland Clinic Foundation Department of Hear Failure/Transplantation, Cleveland

46805

Fort Wayne Cardiology, Fort Wayne

48601

Michigan Cardiovascular Institute, Saginaw

52803

Genesis Medical Center, Davenport

78758

Texas Cardiac Arrhythmia Research, Austin

84157

Intermountain Medical Center, Salt Lake City

99508

Alaska Cardiovascular Research Foundation, Anchorage

T2N 4N1

University of Calgary/Foothills Hospital, Calgary

K7V 2V7

Kingston General Hospital, Kingston

Unknown

Queen Mary Hospital, Pok Fu Lam

Prince of Wales Hospital/The Chinese University of Hong Kong, Shatin

All Listed Sponsors
lead

Medtronic Cardiac Rhythm and Heart Failure

INDUSTRY

NCT00289276 - FAST (Fluid Accumulation Status Trial) | Biotech Hunter | Biotech Hunter